CN Stock MarketDetailed Quotes

600211 Tibet Rhodiola Pharmaceutical Holding

Watchlist
  • 38.61
  • +0.45+1.18%
Not Open Dec 12 15:00 CST
12.44BMarket Cap16.88P/E (TTM)

Tibet Rhodiola Pharmaceutical Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-8.13%2.18B
-11.29%1.61B
-22.35%704.22M
22.69%3.13B
20.93%2.37B
35.52%1.82B
38.22%906.94M
19.45%2.55B
25.37%1.96B
29.41%1.34B
Operating revenue
-8.13%2.18B
-11.29%1.61B
-22.35%704.22M
22.69%3.13B
20.93%2.37B
35.52%1.82B
38.22%906.94M
19.45%2.55B
25.37%1.96B
29.41%1.34B
Other operating revenue
----
34.59%3.66M
----
-35.64%6.24M
----
-19.98%2.72M
----
-19.61%9.69M
----
62.94%3.4M
Total operating cost
-8.96%1.41B
-11.90%1.03B
-23.42%444.14M
13.52%2.06B
11.52%1.55B
20.04%1.17B
30.10%579.96M
15.38%1.81B
27.57%1.39B
37.63%972.66M
Operating cost
-0.07%110.34M
-9.12%69.5M
-9.61%36.39M
5.72%155.08M
3.00%110.42M
5.95%76.48M
11.34%40.26M
-34.28%146.69M
-33.89%107.2M
-29.90%72.19M
Operating tax surcharges
7.78%30.44M
11.63%23.88M
-37.90%6.91M
17.29%38.17M
16.94%28.24M
20.84%21.39M
30.27%11.13M
24.22%32.54M
32.00%24.15M
42.88%17.7M
Operating expense
-8.81%1.21B
-11.15%907.31M
-22.01%395.24M
24.73%1.76B
23.80%1.33B
38.03%1.02B
40.77%506.81M
22.00%1.41B
29.55%1.07B
33.90%739.76M
Administration expense
-8.76%79.71M
-0.82%53.53M
2.52%26.21M
-6.39%124M
-4.07%87.36M
-7.41%53.97M
-8.32%25.56M
33.19%132.47M
61.76%91.07M
77.10%58.3M
Financial expense
-143.91%-41.83M
-173.25%-36.07M
-184.15%-23.53M
-885.60%-33.71M
-261.39%-17.15M
-274.42%-13.2M
-353.65%-8.28M
-36.43%4.29M
348.12%10.63M
920.67%7.57M
-Interest expense (Financial expense)
2.25%9.22M
8.01%5.26M
-25.68%2.41M
-19.25%11.59M
-19.89%9.01M
-38.65%4.87M
-8.67%3.25M
231.71%14.36M
82.44%11.25M
144.45%7.93M
-Interest Income (Financial expense)
-82.80%-50.65M
-127.88%-43M
-137.29%-27.35M
-219.60%-45.78M
-330.39%-27.71M
-711.16%-18.87M
-886.44%-11.53M
-436.87%-14.32M
10.74%-6.44M
53.12%-2.33M
Research and development
104.65%17.03M
34.45%10.52M
-34.72%2.92M
-80.31%17.35M
-89.59%8.32M
-89.85%7.83M
-54.94%4.47M
44.81%88.13M
318.18%79.91M
1,384.53%77.14M
Credit Impairment Loss
-380.75%-362.34K
-119.50%-362.22K
----
-127.64%-150.23K
69.05%-75.37K
31.52%-165.02K
--643.39
-59.94%543.49K
-157.70%-243.53K
-157.09%-240.96K
Asset Impairment Loss
98.46%-47.99K
98.46%-48.05K
----
29.89%-193.97M
92.98%-3.12M
92.98%-3.12M
----
39.94%-276.66M
-3,086.71%-44.49M
-6,027.16%-44.49M
Other net revenue
-12.24%117.2M
841.12%111.32M
787.18%87.18M
36.09%-176.94M
332.97%133.53M
119.89%11.83M
179.10%9.83M
10.80%-276.86M
-1,820.95%-57.32M
-2,491.97%-59.47M
Fair value change income
-50.68%-4.03M
-78.75%-4.37M
-3.06%-2.13M
-1,386.12%-210.53M
83.80%-2.68M
83.48%-2.44M
81.89%-2.06M
-109.24%-14.17M
-676.15%-16.53M
-416.86%-14.8M
Invest income
-43.08%12.57M
-54.94%7.69M
-79.18%2.46M
475.81%40.44M
537.75%22.08M
4,868.63%17.06M
809.69%11.82M
203.58%7.02M
167.71%3.46M
82.77%-357.7K
-Including: Investment income associates
-2.31%-2.28M
-71.08%-1.57M
-25.07%-754.12K
-92.13%-4.27M
27.37%-2.23M
68.94%-919.19K
70.60%-602.97K
77.05%-2.22M
0.98%-3.07M
10.64%-2.96M
Asset deal income
1,895.41%2.08M
1,944.76%2.08M
--168.34K
6,867.21%533.93K
---115.99K
---112.56K
----
121.42%7.66K
----
----
Other revenue
-8.90%106.99M
17,186.97%106.34M
123,872.13%86.68M
2,821.15%186.74M
24,279.71%117.44M
48.00%615.13K
4.96%69.92K
160.28%6.39M
104.14%481.71K
111.56%415.62K
Operating profit
-7.36%884.45M
4.95%697.33M
3.11%347.27M
93.50%899.09M
85.81%954.75M
113.61%664.46M
70.17%336.81M
80.94%464.65M
8.94%513.83M
-6.79%311.06M
Add:Non operating Income
8.58%789.52K
764.43%649.69K
-51.86%209.47K
684.26%2.61M
277.15%727.13K
32.58%75.16K
2,095.82%435.1K
-91.97%332.45K
-96.33%192.79K
-92.79%56.69K
Less:Non operating expense
198.73%2.42M
602.06%2.11M
-75.71%35.93K
120.00%3.51M
-41.81%808.76K
-62.19%300.25K
-53.01%147.95K
-73.83%1.59M
-76.25%1.39M
96.73%794.12K
Total profit
-7.53%882.83M
4.76%695.87M
3.07%347.44M
93.83%898.19M
86.23%954.67M
114.05%664.24M
70.57%337.1M
81.83%463.39M
8.82%512.64M
-7.12%310.32M
Less:Income tax cost
-3.81%87.68M
8.37%69.79M
1.96%32.2M
-0.15%87.95M
38.81%91.15M
42.71%64.4M
47.74%31.58M
110.60%88.08M
32.81%65.67M
33.91%45.13M
Net profit
-7.92%795.15M
4.38%626.08M
3.18%315.24M
115.89%810.24M
93.19%863.52M
126.19%599.83M
73.34%305.52M
76.18%375.31M
6.01%446.97M
-11.72%265.19M
Net profit from continuing operation
-7.92%795.15M
4.38%626.08M
3.18%315.24M
115.89%810.24M
93.19%863.52M
126.19%599.83M
73.34%305.52M
76.18%375.31M
6.01%446.97M
-11.72%265.19M
Less:Minority Profit
-59.90%3.28M
-25.01%2.95M
0.28%2.32M
70.60%9.33M
95.53%8.18M
33.56%3.93M
46.39%2.32M
33.76%5.47M
32.46%4.18M
36.01%2.94M
Net profit of parent company owners
-7.42%791.87M
4.57%623.14M
3.21%312.92M
116.56%800.91M
93.17%855.34M
127.23%595.9M
73.59%303.2M
77.01%369.84M
5.81%442.79M
-12.07%262.25M
Earning per share
Basic earning per share
-7.17%2.46
4.32%1.93
3.28%1.26
116.78%3.23
48.04%2.65
74.53%1.85
74.29%1.22
77.38%1.49
5.92%1.79
-11.67%1.06
Diluted earning per share
-7.17%2.46
4.32%1.93
3.28%1.26
116.78%3.23
48.04%2.65
74.53%1.85
74.29%1.22
77.38%1.49
5.92%1.79
-11.67%1.06
Other composite income
-134.59%-12.08M
-83.86%6.72M
-93.67%1.82M
-80.68%18.24M
-70.10%34.92M
-24.93%41.66M
733.53%28.67M
425.38%94.4M
1,736.85%116.79M
549.07%55.5M
Other composite income of parent company owners
-134.59%-12.08M
-83.86%6.72M
-93.67%1.82M
-80.68%18.24M
-70.10%34.92M
-24.93%41.66M
733.53%28.67M
425.38%94.4M
1,736.85%116.79M
549.07%55.5M
Add:Adjusted items effecting composite income
--6.51K
----
----
----
----
----
----
----
----
----
Total composite income
-12.84%783.07M
-1.35%632.81M
-5.13%317.06M
76.38%828.48M
59.37%898.44M
100.04%641.5M
94.61%334.19M
155.25%469.71M
36.01%563.75M
11.33%320.69M
Total composite income of parent company owners
-12.41%779.79M
-1.21%629.86M
-5.16%314.73M
76.45%819.15M
59.10%890.26M
100.65%637.57M
95.05%331.87M
158.02%464.24M
36.03%559.57M
11.15%317.75M
Total composite income of minority owners
-59.82%3.29M
-25.01%2.95M
0.28%2.32M
70.60%9.33M
95.53%8.18M
33.56%3.93M
46.39%2.32M
33.76%5.47M
32.46%4.18M
36.01%2.94M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Sichuan Huaxin (Group) Accounting Firm (Special General Partnership)
--
--
--
Sichuan Huaxin (Group) Accounting Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -8.13%2.18B-11.29%1.61B-22.35%704.22M22.69%3.13B20.93%2.37B35.52%1.82B38.22%906.94M19.45%2.55B25.37%1.96B29.41%1.34B
Operating revenue -8.13%2.18B-11.29%1.61B-22.35%704.22M22.69%3.13B20.93%2.37B35.52%1.82B38.22%906.94M19.45%2.55B25.37%1.96B29.41%1.34B
Other operating revenue ----34.59%3.66M-----35.64%6.24M-----19.98%2.72M-----19.61%9.69M----62.94%3.4M
Total operating cost -8.96%1.41B-11.90%1.03B-23.42%444.14M13.52%2.06B11.52%1.55B20.04%1.17B30.10%579.96M15.38%1.81B27.57%1.39B37.63%972.66M
Operating cost -0.07%110.34M-9.12%69.5M-9.61%36.39M5.72%155.08M3.00%110.42M5.95%76.48M11.34%40.26M-34.28%146.69M-33.89%107.2M-29.90%72.19M
Operating tax surcharges 7.78%30.44M11.63%23.88M-37.90%6.91M17.29%38.17M16.94%28.24M20.84%21.39M30.27%11.13M24.22%32.54M32.00%24.15M42.88%17.7M
Operating expense -8.81%1.21B-11.15%907.31M-22.01%395.24M24.73%1.76B23.80%1.33B38.03%1.02B40.77%506.81M22.00%1.41B29.55%1.07B33.90%739.76M
Administration expense -8.76%79.71M-0.82%53.53M2.52%26.21M-6.39%124M-4.07%87.36M-7.41%53.97M-8.32%25.56M33.19%132.47M61.76%91.07M77.10%58.3M
Financial expense -143.91%-41.83M-173.25%-36.07M-184.15%-23.53M-885.60%-33.71M-261.39%-17.15M-274.42%-13.2M-353.65%-8.28M-36.43%4.29M348.12%10.63M920.67%7.57M
-Interest expense (Financial expense) 2.25%9.22M8.01%5.26M-25.68%2.41M-19.25%11.59M-19.89%9.01M-38.65%4.87M-8.67%3.25M231.71%14.36M82.44%11.25M144.45%7.93M
-Interest Income (Financial expense) -82.80%-50.65M-127.88%-43M-137.29%-27.35M-219.60%-45.78M-330.39%-27.71M-711.16%-18.87M-886.44%-11.53M-436.87%-14.32M10.74%-6.44M53.12%-2.33M
Research and development 104.65%17.03M34.45%10.52M-34.72%2.92M-80.31%17.35M-89.59%8.32M-89.85%7.83M-54.94%4.47M44.81%88.13M318.18%79.91M1,384.53%77.14M
Credit Impairment Loss -380.75%-362.34K-119.50%-362.22K-----127.64%-150.23K69.05%-75.37K31.52%-165.02K--643.39-59.94%543.49K-157.70%-243.53K-157.09%-240.96K
Asset Impairment Loss 98.46%-47.99K98.46%-48.05K----29.89%-193.97M92.98%-3.12M92.98%-3.12M----39.94%-276.66M-3,086.71%-44.49M-6,027.16%-44.49M
Other net revenue -12.24%117.2M841.12%111.32M787.18%87.18M36.09%-176.94M332.97%133.53M119.89%11.83M179.10%9.83M10.80%-276.86M-1,820.95%-57.32M-2,491.97%-59.47M
Fair value change income -50.68%-4.03M-78.75%-4.37M-3.06%-2.13M-1,386.12%-210.53M83.80%-2.68M83.48%-2.44M81.89%-2.06M-109.24%-14.17M-676.15%-16.53M-416.86%-14.8M
Invest income -43.08%12.57M-54.94%7.69M-79.18%2.46M475.81%40.44M537.75%22.08M4,868.63%17.06M809.69%11.82M203.58%7.02M167.71%3.46M82.77%-357.7K
-Including: Investment income associates -2.31%-2.28M-71.08%-1.57M-25.07%-754.12K-92.13%-4.27M27.37%-2.23M68.94%-919.19K70.60%-602.97K77.05%-2.22M0.98%-3.07M10.64%-2.96M
Asset deal income 1,895.41%2.08M1,944.76%2.08M--168.34K6,867.21%533.93K---115.99K---112.56K----121.42%7.66K--------
Other revenue -8.90%106.99M17,186.97%106.34M123,872.13%86.68M2,821.15%186.74M24,279.71%117.44M48.00%615.13K4.96%69.92K160.28%6.39M104.14%481.71K111.56%415.62K
Operating profit -7.36%884.45M4.95%697.33M3.11%347.27M93.50%899.09M85.81%954.75M113.61%664.46M70.17%336.81M80.94%464.65M8.94%513.83M-6.79%311.06M
Add:Non operating Income 8.58%789.52K764.43%649.69K-51.86%209.47K684.26%2.61M277.15%727.13K32.58%75.16K2,095.82%435.1K-91.97%332.45K-96.33%192.79K-92.79%56.69K
Less:Non operating expense 198.73%2.42M602.06%2.11M-75.71%35.93K120.00%3.51M-41.81%808.76K-62.19%300.25K-53.01%147.95K-73.83%1.59M-76.25%1.39M96.73%794.12K
Total profit -7.53%882.83M4.76%695.87M3.07%347.44M93.83%898.19M86.23%954.67M114.05%664.24M70.57%337.1M81.83%463.39M8.82%512.64M-7.12%310.32M
Less:Income tax cost -3.81%87.68M8.37%69.79M1.96%32.2M-0.15%87.95M38.81%91.15M42.71%64.4M47.74%31.58M110.60%88.08M32.81%65.67M33.91%45.13M
Net profit -7.92%795.15M4.38%626.08M3.18%315.24M115.89%810.24M93.19%863.52M126.19%599.83M73.34%305.52M76.18%375.31M6.01%446.97M-11.72%265.19M
Net profit from continuing operation -7.92%795.15M4.38%626.08M3.18%315.24M115.89%810.24M93.19%863.52M126.19%599.83M73.34%305.52M76.18%375.31M6.01%446.97M-11.72%265.19M
Less:Minority Profit -59.90%3.28M-25.01%2.95M0.28%2.32M70.60%9.33M95.53%8.18M33.56%3.93M46.39%2.32M33.76%5.47M32.46%4.18M36.01%2.94M
Net profit of parent company owners -7.42%791.87M4.57%623.14M3.21%312.92M116.56%800.91M93.17%855.34M127.23%595.9M73.59%303.2M77.01%369.84M5.81%442.79M-12.07%262.25M
Earning per share
Basic earning per share -7.17%2.464.32%1.933.28%1.26116.78%3.2348.04%2.6574.53%1.8574.29%1.2277.38%1.495.92%1.79-11.67%1.06
Diluted earning per share -7.17%2.464.32%1.933.28%1.26116.78%3.2348.04%2.6574.53%1.8574.29%1.2277.38%1.495.92%1.79-11.67%1.06
Other composite income -134.59%-12.08M-83.86%6.72M-93.67%1.82M-80.68%18.24M-70.10%34.92M-24.93%41.66M733.53%28.67M425.38%94.4M1,736.85%116.79M549.07%55.5M
Other composite income of parent company owners -134.59%-12.08M-83.86%6.72M-93.67%1.82M-80.68%18.24M-70.10%34.92M-24.93%41.66M733.53%28.67M425.38%94.4M1,736.85%116.79M549.07%55.5M
Add:Adjusted items effecting composite income --6.51K------------------------------------
Total composite income -12.84%783.07M-1.35%632.81M-5.13%317.06M76.38%828.48M59.37%898.44M100.04%641.5M94.61%334.19M155.25%469.71M36.01%563.75M11.33%320.69M
Total composite income of parent company owners -12.41%779.79M-1.21%629.86M-5.16%314.73M76.45%819.15M59.10%890.26M100.65%637.57M95.05%331.87M158.02%464.24M36.03%559.57M11.15%317.75M
Total composite income of minority owners -59.82%3.29M-25.01%2.95M0.28%2.32M70.60%9.33M95.53%8.18M33.56%3.93M46.39%2.32M33.76%5.47M32.46%4.18M36.01%2.94M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Sichuan Huaxin (Group) Accounting Firm (Special General Partnership)------Sichuan Huaxin (Group) Accounting Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Traditional Chinese Medicine Concept
Traditional Chinese Medicine Concept
Intraday+1.64%
Brain science (brain-computer interface)
Brain science (brain-computer interface)
Intraday+1.56%
Biological Vaccine
Biological Vaccine
Intraday+1.24%